Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM

"123 I-FP-CIT (DATSCAN) : 185 MBq (5 mCi), 2,5 ml will be injected via an arm intravenous catheter.~123I-ADAM:185 MBq,5 ml will be injected via an arm intravenous catheter."

Trial Locations (2)

37044

Bretonneau Hospital, Tours

75013

Salpêtrière Hospital, Paris

All Listed Sponsors
collaborator

Association Française contre les Myopathies (AFM), Paris

OTHER

collaborator

ARS (Association pour la Recherche sur la Sclérose Latérale Amyotrophique)

UNKNOWN

collaborator

Agence Générale des Equipements et Produits de Santé

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01160263 - Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls | Biotech Hunter | Biotech Hunter